Are Amrutanjan Healt latest results good or bad?

Amrutanjan Health Care has reported its financial results for the quarter ending March 2025, which reflect a flat performance compared to previous quarters. The company experienced an adjustment in its evaluation over the last three months. In terms of financial metrics, the net sales for the quarter reached Rs 135.41 crore, marking a year-on-year growth of 6.57%. This growth rate is lower than the 26.65% growth observed in the same quarter of the previous year. The standalone net profit for the quarter also showed a year-on-year growth of 11.13%, compared to 7.56% in the prior year, indicating a positive trend in profitability. For the nine-month period ending March 2025, the Profit After Tax (PAT) stands at Rs 46.23 crore, reflecting a year-on-year growth of 21.79%. This figure surpasses the previous PAT of Rs 42.58 crore for the same period last year, suggesting that the company has already exceeded its sales from the prior year within just nine months. Overall, while Amrutanjan Health Care's quarterly performance shows some positive indicators, the overall evaluation reflects a more cautious outlook.